-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LD2UkpW8hpRzcEsj7RPftRvbRE3K7Oo6GMnoeC9rDg95oVGu/IuD3keNHPeftr5s M8wLy8BWpwTJAuE6LE6PhA== 0001144204-03-000424.txt : 20030210 0001144204-03-000424.hdr.sgml : 20030210 20030210133049 ACCESSION NUMBER: 0001144204-03-000424 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030210 GROUP MEMBERS: BRUCE BERNSTEIN GROUP MEMBERS: OLIVIER MORALI GROUP MEMBERS: OMICRON CAPITAL INC. GROUP MEMBERS: OMICRON CAPITAL LP GROUP MEMBERS: OSKAR P. LEWNOWSKI GROUP MEMBERS: WINCHESTER GLOBAL TRUST COMPANY LTD FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OMICRON MASTER TRUST CENTRAL INDEX KEY: 0001217111 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: WINCHESTER GLOBAL TRUST CO STREET 2: WILLIAMS HOUSE, 20 REID STREET CITY: HAMILTON STATE: A1 ZIP: 00000 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-49329 FILM NUMBER: 03546651 BUSINESS ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9497886700 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 SC 13G 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________ SCHEDULE 13G Information Statement pursuant to Rule 13d-1 and 13d-2 ____________________________________ Spectrum Pharmaceuticals ------------------------ (Name of Issuer) COMMON STOCK ($0.01 par value) ------------------------------ (Title of Class of Securities) 640656104 --------- (CUSIP Number) January 16, 2003 (Date of event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ X] Rule 13d-1(c) [ ] Rule 13d-1(d) (Continued on following pages) (Page 1 of 16 Pages)
Page 2 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Omicron Master Trust - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Bermuda - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a)) REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON PN - --------------------------------------------------------------------------------
Page 3 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Omicron Capital, L.P. 52-2057093 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH None. REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON PN - --------------------------------------------------------------------------------
Page 4 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Omicron Capital, Inc. 52-2032702 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH None. REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON CO - --------------------------------------------------------------------------------
Page 5 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Bruce Bernstein - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: United States of America - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH None. REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------------------
Page 6 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Olivier Morali - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: France - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH None. REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------------------
Page 7 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Winchester Global Trust Company Limited - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Bermuda - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a)) REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON CO - --------------------------------------------------------------------------------
Page 8 of 16 Pages 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Oskar P. Lewnowski - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] (See Item 6) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Austria - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF SHARES None. BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH 250,701 shares of Common Stock of the Issuer (see Item 4(a)) REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH None. 8. SHARED DISPOSITIVE POWER 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 250,701 shares of Common Stock of the Issuer (see Item 4(a)) - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.5% (See Item 4(a)) - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------------------
ITEM 1(a). NAME OF REPORTING PERSON Spectrum Pharmaceuticals, Inc. (the "Issuer") ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES. 157 Technology Drive Irvine, CA 92618 ITEM 2(a). NAMES OF PERSON FILING. Omicron Master Trust ("Omicron Trust") Omicron Capital, L.P. ("Omicron Capital") Omicron Capital, Inc. ("OCI") Bruce Bernstein ("Bernstein") Olivier Morali ("Morali") Winchester Global Trust Company Limited ("WGTCL") Oskar P. Lewnowski ("Lewnowski") Page 9 of 16 Pages ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE. THE ADDRESS OF THE PRINCIPAL BUSINESS OFFICE IS: Omicron Trust - c/o Olympia Capital International Inc., Williams House, 20 Reid Street, Hamilton HM11, Bermuda Omicron Capital - 153 E. 53rd Street, 48th Floor, New York, New York 10022 OCI - 153 E. 53rd Street, 48th Floor, New York, New York 10022 Bernstein - 153 E. 53rd Street, 48th Floor, New York, New York 10022 Morali - 153 E. 53rd Street, 48th Floor, New York, New York 10022 WGTCL - c/o Winchester Fiduciary Limited, Williams House, 20 Reid Street, Hamilton HM11, Bermuda Lewnowski - c/o Winchester Fiduciary Limited, Williams House, 20 Reid Street, Hamilton HM11, Bermuda ITEM 2(c). CITIZENSHIP. Omicron Trust - Bermuda Omicron Capital - Delaware OCI - Delaware Bernstein - United States of America Morali - France WGTCL - Bermuda Lewnowski - Austria ITEM 2(d). TITLE OF CLASS OF SECURITIES. Common Stock, $0.01 par value per share of the Issuer (the "Common Stock") ITEM 2(e). CUSIP NUMBER. 640656104 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: This statement is filed pursuant to Rule 13d-1(c) by Omicron Trust, Omicron Capital, OCI, Bernstein, Morali, WGTCL and Lewnowski. Page 10 of 16 Pages ITEM 4. OWNERSHIP. (a) Amount Beneficially Owned: Omicron Trust: 250,701 shares* Omicron Capital: 250,701 shares* OCI: 250,701 shares* Morali: 250,701 shares* Bernstein: 250,701 shares WGTCL: 250,701 shares* Lewnowksi: 250,701 shares* (b) Percent of Class: Omicron Partners: 8.5% Omicron Capital: 8.5% OCI: 8.5% Bernstein: 8.5% Morali: 8.5% WGTCL: 8.5% Lewnowski: 8.5% (based on 2,948,242 shares of Common Stock of the Issuer issued and outstanding as January 17, 2003 as stated in the Issuer's prospectus supplement on form 424(b)(3) dated January 29, 2003) (c) Number of Shares as to which the Person has: Omicron Trust, WGTCL and Lewnowski: ---------------------------------- (i) sole power to vote or to direct the vote: none (ii) shared power to vote or to direct the vote: 250,701 shares of Common Stock:* (iii) sole power to dispose or to direct the disposition of: none (iv) shared power to dispose or to direct the disposition of: 250,701 shares of Common Stock* Omicron Capital, OCI, Bernstein and Morali: ------------------------------------------ (i) sole power to vote or to direct the vote: none Page 11 of 16 Pages (ii) shared power to vote or to direct the vote: none (iii) sole power to dispose or to direct the disposition of: none (iv) shared power to dispose or to direct the disposition of: 250,701 shares of Common Stock* *Omicron Capital serves as investment manager to Omicron Trust. By reason of such relationship, Omicron Capital may be deemed to share dispositive power over the shares of Common Stock owned by Omicron Partners. Omicron Trust disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by Omicron Trust or any other person reporting on this Schedule. OCI serves as general partner of Omicron Capital. By reason of such relationship, OCI may be deemed to share dispositive power over the shares of Common Stock listed as beneficially owned by Omicron Capital. OCI disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by Omicron Capital or any other person reporting on this Schedule. Morali serves as president and a director and is a stockholder of OCI. By reason of such relationships, Morali may be deemed to share dispositive power over the shares of Common Stock listed as beneficially owned by OCI. Morali disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by OCI or any other person reporting on this Schedule. Bernstein serves as an officer of OCI. By reason of such relationships, Bernstein may be deemed to share dispositive power over the shares of Common Stock listed as beneficially owned by OCI. Bernstein disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by OCI or any other person reporting on this Schedule. WGTCL serves as trustee of Omicron Trust. By reason of such relationship, WGTCL may be deemed to shares voting and dispositive power over the shares of Common Stock listed as beneficially owned by Omicron Trust. WGTCL disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by Omicron Trust or any other person reporting on this Schedule. WGTCL may be deemed to be controlled by Lewnowski. By reason of such control, Lewnowski may be deemed to share voting and dispositive power over the shares of Common Stock listed as beneficially owned by WGTCL. Lewnowski disclaims beneficial ownership of the shares of Common Stock listed as beneficially owned by WGTCL. Certain of the shares of Common Stock reported as beneficially owned are shares that Omicron Trust has the right to acquire upon exercise of warrants to purchase Common Stock held by Omicron Trust. Omicron Capital, OCI, Bernstein, Morali, WGTCL and Lewnowski each disclaims beneficial ownership of such shares of Common Stock. Page 12 of 16 Pages Of the shares of Common Stock reported as beneficially owned, 77,572 shares of Common Stock are shares which Omicron Trust has the right to acquire upon exercise of warrants of the Issuer. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction which could have that purpose or effect. EXHIBITS: Exhibit I: Joint Filing Agreement, dated as of February 7, 2003, by and among Omicron Trust, Omicron Capital, OCI, Bernstein, Morali, WGTCL and Lewnowski. Page 13 of 16 Pages SIGNATURE By signing below each signatory certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Date: February 7, 2003 OMICRON MASTER TRUST By: OMICRON CAPITAL, L.P., Investment Manager By: OMICRON CAPITAL, INC., General Partner By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President OMICRON CAPITAL, L.P. By: OMICRON CAPITAL, INC., General Partner By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President OMICRON CAPITAL, INC. By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein /s/ Olivier Morali - ---------------------------- Olivier Morali Page 14 of 16 Pages WINCHESTER GLOBAL TRUST COMPANY LIMITED By: /s/ Oskar P. Lewnowksi - ---------------------------- Oskar P. Lewnowski, Chairman /s/ Oskar P. Lewnowksi - --------------------------- Oskar P. Lewnowski Page 15 of 16 Pages Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the amendment to Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, $.01 par value, of Spectrum Pharmaceuticals, a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated as of February 7, 2003 OMICRON MASTER TRUST By: OMICRON CAPITAL, L.P., Investment Manager By: OMICRON CAPITAL, INC., General Partner By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President OMICRON CAPITAL, L.P. By: OMICRON CAPITAL, INC., General Partner By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President OMICRON CAPITAL, INC. By: /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein, President /s/ Bruce Bernstein - ---------------------------- Bruce Bernstein /s/ Olivier Morali - ---------------------------- Olivier Morali Page 16 of 16 Pages WINCHESTER GLOBAL TRUST COMPANY LIMITED By: /s/ Oskar P. Lewnowksi - ---------------------------- Oskar P. Lewnowski, Chairman /s/ Oskar P. Lewnowksi - ---------------------------- Oskar P. Lewnowski -----END PRIVACY-ENHANCED MESSAGE-----